India’s Ayush services sector reached a valuation of $36.92 billion in fiscal 2024-25, growing at nearly 17% annually. Fueled by medical tourism and standardized care, the industry is projected to hit $318 billion by 2047. Investors are monitoring how standardized quality and digital records impact the sector's long-term growth.
The Ayush services sector in India has evolved from a traditional niche into a significant part of the national economy. According to a report by the Research and Information System for Developing Countries (RIS), the sector generated $36.92 billion in revenue during the 2024-25 fiscal year. With an annual growth rate of nearly 17% since 2022-23, the industry is seeing a clear shift toward organized, standardized care. Clinics and day-care facilities now drive over 71% of the sector's total revenue.
Segment Drivers and Medical Tourism
Ayurveda continues to hold the largest share of the market, contributing $17.73 billion, or about 48% of the total revenue. Meanwhile, the wellness segment, which includes yoga centers and specialized resorts, is growing at a faster pace of over 21% annually. A major driver of this growth is medical value travel, where international patients seek treatments like Panchakarma. While these international visitors represent only 5% of the total patient volume, they contribute between 15% and 25% of the revenue in the hospital segment due to the longer, specialized nature of their care.
Quality and Digital Transformation
The ability of Ayush providers to attract both domestic and international patients is increasingly tied to digital accessibility and institutional quality. Data shows that providers with dedicated websites receive over three times as many inquiries from abroad. Furthermore, certifications such as NABH or ISO status are becoming essential for building trust, as centers with these credentials often see double the patient engagement compared to non-certified facilities. The industry's path to the projected $318 billion valuation by 2047 will rely heavily on improving digital health records, infrastructure, and workforce training.
Investor and Market Context
For investors, the formalization of the Ayush sector carries important implications. Many large Indian consumer goods companies, such as Dabur and Emami, already have significant portfolios in traditional medicine, and the sector's growth is often linked to the performance of these broader healthcare and FMCG segments. However, the industry still faces the challenge of quality standardization. Investors often monitor regulatory compliance and research-backed clinical data, as these are critical for ensuring long-term credibility in the global market. The integration of traditional knowledge with modern technology remains a key area for development. Going forward, the most important updates to track will be the adoption of stricter quality benchmarks, the pace of new digital health infrastructure projects, and the expansion of medical value travel policies that encourage international patient inflow.